Short QT Interval Prevalence and Clinical Outcomes in a Pediatric Population

Karine Guerrier1, David Kwiatkowski2, Richard J Czosek2

  • 1From the Department of Cardiology, Cincinnati Children's Hospital Medical Center, The Heart Institute, OH (K.G., R.J.C., D.S.S., J.B.A., T.K.K.); and Department of Cardiology, The Heart Center, Lucile Packard Children's Hospital, Palo Alto, CA (D.K.). Karine.Guerrier@cchmc.org.

Insights

Short QT interval is rare in children, affecting 0.05% of patients. This study found no unifying clinical characteristics for pediatric patients with short QT intervals, though males predominated.

Area of Science:

  • Cardiology
  • Pediatric Electrophysiology

Background:

  • Short QT interval (SQT) risk is recognized, but pediatric prevalence data are limited.
  • European adult studies report SQT prevalence from 0.02% to 0.1%.
  • This study addresses the gap in pediatric SQT prevalence research.

Purpose of the Study:

  • To determine the prevalence of short QT interval in a pediatric population.
  • To identify associated clinical characteristics and outcomes in pediatric patients with SQT.
  • To compare symptomatic and asymptomatic pediatric patients with SQT.

Main Methods:

  • Retrospective review of ECGs from a single pediatric institution.
  • Database query for patients ≤21 years with QTc 140-340 ms, confirmed by pediatric electrophysiologist.
  • Chart review for clinical characteristics, symptoms, and outcomes; comparison of symptomatic vs. asymptomatic groups.

Main Results:

  • Prevalence of short QT interval (QTc ≤340 ms) was 0.05% (45/99,380 patients).
  • Median age was 15 years; median QTc was 323 ms.
  • Women had significantly shorter QTc than men (312 vs. 323 ms; P=0.03). Two deaths occurred (respiratory failure, unknown cause with dilated cardiomyopathy).

Conclusions:

  • Short QT interval is a rare finding in pediatric patients (0.05% prevalence).
  • Male predominance was observed, but women had shorter QTc intervals.
  • No unifying clinical characteristics were identified for this pediatric SQT cohort.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
474
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
745
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
335
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.1K